ReviewFrontiers in pharmacology2021

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option.

Manuel Kraft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.